Development and characterization of heparin immobilized bacterial cellulose(BC) for bone tissue engineering using gamma-irradiation

Tissue Engineering and Regenerative Medicine

Volumn 11, Issue SUPPL. 2, 2014, Pages 56-63

  Jeong, Sung In ^a   Jeong, Jin Oh ^a   Choi, Jong Bae ^a   Shin, Young Min ^a   Park, Jong Seok ^a   Gwon, Hui Jeong ^a   Nho, Young Chang ^a   An, Sung Jun ^b   Park, Man Young ^b   Lim, Youn Mook ^a  

^a Korea Atomic Energy Research Institute   (South Korea)

^b Jadam Co   (South Korea)

Author keywords

2 aminoethyl methacrylate; bacterial cellulose; gamma irradiation; heparin; Tissue engineering

Indexed keywords

BONE; CELLULOSE; SURFACE MORPHOLOGY; TISSUE; TISSUE ENGINEERING;

2-AMINOETHYL METHACRYLATE; BACTERIAL CELLULOSE; BONE TISSUE ENGINEERING; FLUORESCAMINES; GAMMA IRRADIATION; GLUCONACETOBACTER HANSENII; HEPARIN; TISSUE SCAFFOLDS;

SCAFFOLDS (BIOLOGY);

BACTERIAL CELLULOSE; BACTERIAL POLYSACCHARIDE; BONE MORPHOGENETIC PROTEIN 2; CELLULOSE; CHOLECYSTOKININ OCTAPEPTIDE; FLUORESCAMINE; HEPARIN; METHACRYLIC ACID 2 AMINOETHYL ESTER; METHACRYLIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BONE TISSUE; CELL PROLIFERATION; CHEMICAL REACTION; GAMMA IRRADIATION; GEL; GLUCONACETOBACTER; GLUCONACETOBACTER HANSENII; IMMOBILIZATION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; TISSUE ENGINEERING; TISSUE SCAFFOLD;

EID: 84906667976     PISSN: 17382696     EISSN: 22125469     Source Type: Journal    
DOI: 10.1007/s13770-014-0424-x     Document Type: Article

References (33)

1. JB Choi, SI Jeong, HJ Gwon, et al., Preparation and characterization of Gelatin-immobilized Bacterial Cellulose Scaffold for Tissue Engineering Using Gamma-ray Irradiation. Journal of Radiation Industry, 6, 159 (2012).
2. ME Embuscado, JS Marks and JN BeMiller, Optimization of cellulose production by acetobacter xylinum through response surface methodology. Food Hydrocoll, 8, 419 (1994).
3. EJ Vandamme, SD Baets, A Vanbaelen, et al., Improved production of bacterial cellulose and its application potential. Polym Degrad Stab. 59, 93 (1998).
4. HJ Gwon, YM Shin, JB Choi, et al., Characterization of Microbial Fermented Cellulose Porous Foam Prepared by Radiation Treatment. Korean J. Environ. Biol. 31, 302 (2013).
5. KH Choi, JS Jeong, CH Moon, et al., Optimization of culture condition of Gluconacetobacter hansenii TF-2 for cellulose gel fermentation. J. Korean Soc. Food Sci. Nutr. 33, 176, (2004a).
6. KH Choi, JS Jeong, CH Moon, et al., Effect of carbon source supplement on the gel production from citrus juice by Gluconacetobacter hansenii TL-2C. J. Korean Soc. Food Sci. Nutr. 33, 170, (2004b).
7. JM Lee, WI Choi, GY Tae, et al., Enhanced regeneration of the ligament-bone interface using a poly(L-lactide-co-e- caprolactone) scaffold with local delivery of cells/BMP-2 using a heparin-based hydrogel. Acta Biomaterialia, 7, 244, (2011).
8. SW Kim, WG La, JM Kang, et al., Comparison of Osteogenic Potential between Adipose-Derived Stem Cells and BMP-2 in a Mouse Calvarial Defect Model. Tissue Engineering and Regenerative Medicine, 4, 382 (2007).
9. AK Katherine, S Tanaka, et al., Murine bone marrow stromally derived BMS2 adipocytes support differentiation and function of osteoclast-like cells in vitro. Endocrinology, 139, 2092 (1998).
10. EK Lee, YS Son, Recent progress in adipose tissue engineering, Tissue Eng. Med, 396 (2006).
11. A Yamaguchi, T Ishuzuya, N Kintou, et al., Effect of BMP-2, BMP-4, and BMP-6 on ostedblastic differentiation of bone marrow-derived stromal cell line, ST2 and MC3T3-G2/PA6. Biochem Biophys Res Commun. 220, 366, (1996).
12. RB Rutherford, M Moalli, RT Franceschi, et al., Bone morphogenetic protein-transdeced human fibroblasts convert to osteoblasts and form bone in vivo. Tissue Eng, 8, 441, (2002).
13. U Valcourt, J Gouttenoire, A Moustakas, et al., Functions of transforming growth factor-β family type I receptors and smad proteins in the hypertrophic maturation and osteoblastic differentiation of chondrocytes. J Biol Chem, 277, 33545, (2002).
14. M Mehta, K Schmidt-Bleek, GN Duda, et al., Biomaterial delivery of morphogens to mimic the natural healing cascade in bone. Adv Drug Deliv Rev, 64, 1257, (2012).
15. SH Lee, JY Jo, MJ Yun, et al., Effect of immobilization of the recombinant human bone morphogenetic protein 2 (rhBMP-2) on anodized implants coated with heparin for improving alveolar ridge augmentation in beagle dogs: Radiographic observations. The journal of advanced prosthodontics, 4, 51, (2013).
16. UM Wikesjo, M Qahash, RC Thomson, et al., Space-providing expanded polytetrafluoroethylene devices define alveolar ugmentation at dental implants induced by recombinant human bone morphogenetic protein 2 in an absorbable collagen sponge carrier. Clin Implant Dent Relat Res, 5, 112 (2003).
17. J Kim, Y Park, G Tae, et al., haracterization of low-molecularweight hyaluronic acid-based hydrogel and ifferential stem cell responses in the hydrogel microenvironments. J Biomed Mater Res A, 88, 967, (2009).
18. TC Lee, JT Ho, KS Hung, et al., Bone morphogenetic protein gene therapy using a fibrin scaffold for a rabbit spinal-fusion experiment. Neurosurgery, 58, 373, (2006).
19. R Sasisekharan, S Ernst, G Venkataraman, On the regulation of fibroblast growth factor activity by heparin-like glycosaminoglycans. Angiogenesis, 1, 45, (1997).
20. I Capila, RJ Kinhardt, Heparin-protein interactions, Angew. Chem. Int. Ed. 41, 390 (2002).
21. KY Joung and KD Park, Controlled Release Systems of Growth Factors Using Heparinized Polymeric Carriers. Tissue Engineering and Regenerative Medicine, 5, 156 (2008).
22. A Perets, Y Baruch, F Weisbuch, et al., Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. J Biomed Mater Res A, 65, 489 (2003).
23. JB Huh, SE Kim, SK Song, et al., The effect of immobilization of heparin and bone morphogenic protein-2 to bovine bone substitute on osteoblast-like cell's function. J Adv Prosthodont, 3, 145, (2011).
24. SE Kim, SH Song, YP Yun, et al., The effect of immobilization of heparin and bone morphogenic protein-2 (BMP-2) to titanium surfaces on inflammation and osteoblast function. Biomaterials, 32, 366, (2011).
25. T Ishibe, T Goto, T Kodama, et al., Bone formation on apatite-coated titanium with incorporated BMP-2/heparin in vivo. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 108, 867, (2009).
26. YM Shin, JY Lim, JS Park, et al., Radiation-induced Biomimetic Modification of Dual-layered Nano/Microfibrous Scaffolds for Vascular Tissue Engineering. Biotechnology and Bioprocess Engineering, 19, 118, (2014)
27. YM Shin, KS Kim, YM Lim, et al., Modulation of Spreading, Proliferation, and Differentiation of Human Mesenchymal Stem Cells on Gelatin-Immobilized Poly(L-lactide-co-Ecaprolactone) Substrates. Biomacromolecules, 9, 1772, (2008).
28. AH Theresa, T Yasuhiko, GM Antoniosm, In vitro release of transforming growth factor-b1 from gelatin microparticles encapsulated in biodegradable, injectable oligo(poly(ethylene glycol) fumarate) hydrogels. Journal of Controlled Release, 91, 299 (2003).
29. JS Son, KD Park, SH Oh, et al., Preparation and Characterization of Porous Heparin-immobilized PLGA Scaffolds Using Novel Solid Hydrogen Peroxide for Cartilage Regeneration. Tissue Engineering and Regenerative Medicine, 5, 528 (2008).
30. L GrØndahl, A Chandler-Temple and M Trau, Polymeric grafting of acrylic acid onto poly(3-hydroxybutyrate-co-3-hydroxyvalerate): surface functionalization for tissue engineering application. Biomacromolecules, 6, 2197 (2005).
31. YP Yun, SE Kim, EY Kang, et al., The Effect of Bone Morphogenic Protein-2 (BMP-2)-Immobilizing Heparinized- Chitosan scaffolds for Enhanced Osteoblast Activity. Tissue Engineering and Regenerative Medicine, 10, 122 (2013).
32. BE Bax, JM Wozney, DE Ashhurst, Bone morphogenetic protein-2 increases the rate of callus formation after fracture of the rabbit tibia, Calcif Tissue Int, 65, 83 (1999).
33. J Kim, IS Kim, TH Cho, et al., Bone regeneration using hyaluronic acid-based hydrogel with bone morphogenic protein-2 and human mesenchymal stem cells, Biomaterials, 28, 1830 (2007).